Third strand-mediated psoralen-induced correction of the sickle cell mutation on a plasmid transfected into COS-7 cells

Gene Therapy

Volumn 14, Issue 2, 2007, Pages 173-179

  Varganov, Y ^a   Amosova, O ^a   Fresco, J R ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; CELL DNA; MACROGOL; PSORALEN;

ANIMAL CELL; ARTICLE; BASE PAIRING; CELL STRAIN COS7; CONTROLLED STUDY; DNA ADDUCT; DNA ISOLATION; DNA REPAIR; DRUG MECHANISM; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; MONKEY; MUTANT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLASMID VECTOR; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SICKLE CELL; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA ADDUCTS; DNA REPAIR; GENE THERAPY; GENETIC ENGINEERING; GLOBINS; HUMANS; PLASMIDS; POINT MUTATION; PSORALENS; TRANSFECTION;

EID: 33845987085     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302850     Document Type: Article

References (35)

1. May C, Rivella S, Callegari J, Heller G, Gaensler KM, Luzzatto L et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000; 406: 82-86.
2. Persons DA. Update on gene therapy for hemoglobin disorders. Curr Opin Mol Ther 2003; 5: 508-516.
3. Sadelain M, Rivella S, Lisowski L, Samakoglu S, Riviere I. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease. Best Pract Res Clin Haematol 2004; 17: 517-534.
4. Cole-Strauss A, Yoon K, Xiang Y, Byrne BC, Rice MC, Gryn J et al. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide. Science 1996; 273: 1386-1389.
5. Li ZH, Liu DP, Yin WX, Guo ZC, Liang CC. Targeted correction of the point mutations of beta-thalassemia and targeted mutagenesis of the nucleotide associated with HPFH by RNA/DNA oligonucleotides: Potential for beta-thalassemia gene therapy. Blood Cells Mol Dis 2001; 27: 530-538.
6. Liu H, Agarwal S, Kmiec E, Davis BR. Targeted beta-globin gene conversion in human hematopoietic CD34(+) and Lin(-)CD38(-) cells. Gene Therapy 2002; 9: 118-126.
7. Yin W, Kren BT, Steer CJ. Site-specific base changes in the coding or promoter region of the human beta- and gamma-globin genes by single-stranded oligonucleotides. Biochem J 2005; 390:
8. Taubes G. Gene therapy. The strange case of chimeraplasty. Science 2002; 298: 2116-2120.
9. van der Steege GS-HP, Buys CHCM, Scheffer H, Pas HH, Jonkman MF. Persistent failures in gene repair. Nat Biotechnol 2001; 19: 305-306.
10. Parekh-Olmedo H, Ferrara L, Brachman E, Kmiec EB. Gene therapy progress and prospects: Targeted gene repair. Gene Therapy 2005; 12: 639-646.
11. Barre FX, Ait-Si-Ali S, Giovannangeli C, Luis R, Robin P, Pritchard LL et al. Unambiguous demonstration of triple-helix-directed gene modification. Proc Natl Acad Sci USA 2000; 97: 3084-3088.
12. Wang G, Glazer PM. Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix. J Biol Chem 1995; 270: 22595-22601.
13. Vasquez KM, Wang G, Havre PA, Glazer PM. Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells. Nucleic Acids Res 1999; 27: 1176-1181.
14. Havre PA, Gunther EJ, Gasparro FP, Glazer PM. Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc Natl Acad Sci USA 1993; 90: 7879-7883.
15. Luo Z, Macris MA, Faruqi AF, Glazer PM. High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci USA 2000; 97: 9003-9008.
16. Ingram VM. Gene mutations in human haemoglobin: The chemical difference between normal and sickle cell haemoglobin. Nature 1957; 180: 326-328.
17. Friedman M. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci USA 1978; 75: 1994-1997.
18. Broitman S, Amosova O, Dolinnaya NG, Fresco JR. Repairing the sickle cell mutation. I. Specific covalent binding of a photoreactive third strand to the mutated base pair. J Biol Chem 1999; 274: 21763-21768.
19. Amosova O, Broitman SL, Fresco JR. Repairing the Sickle Cell mutation. II. Effect of psoralen linker length on specificity of formation and yield of third strand-directed photoproducts with the mutant target sequence. Nucleic Acids Res 2003; 31: 4673-4681.
20. Beal PA, Dervan PB. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science 1991; 251: 1360-1363.
21. Letai AG, Palladino MA, Fromm E, Rizzo V, Fresco JR. Specificity in formation of triple-stranded nucleic acid helical complexes: Studies with agarose-linked polyribonucleotide affinity columns. Biochemistry 1988; 27: 9108-9112.
22. Gamper HB, Stamm MR, Podyminogin MA, Meyer R. Strand Invasion of supercoiled DNA by oligonucleotides with a triplex guide sequence. J Am Chem Soc 1998; 120: 2182-2183.
23. Fossella JA, Kim YJ, Shih H, Richards EG, Fresco JR. Relative specificities in binding of Watson-Crick base pairs by third strand residues in a DNA pyrimidine triplex motif. Nucleic Acids Res 1993; 21: 4511-4515.
24. Yoon K, Hobbs CA, Koch J, Sardaro M, Kutny R, Weis AL. Elucidation of the sequence-specific third-strand recognition of four Watson-Crick base pairs in a pyrimidine triple-helix motif: T.AT, C.GC, T.CG, and G.TA. Proc Natl Acad Sci USA 1992; 89: 3840-3844.
25. Mergny J, Sun J, Rougee M, Montenaygarestier T, Barcelo F, Chomilier J et al. Sequence specificity in triple helix formation: Experimental and theoretical studies of the effect of mismatches on triplex stability. Biochemistry 1991; 30: 9791-9798.
26. Cimino GD, Gamper HB, Isaacs ST, Hearst JE. Psoralens as photoactive probes of nucleic acid structure and function: Organic chemistry, photochemistry, and biochemistry. Ann Rev Biochem 1985; 54: 1151-1193.
27. Broitman SL, Amosova O, Fresco JR. Repairing the Sickle Cell mutation. III. Effect of irradiation wavelength on the specificity and type of photoproduct formed by a 3′-terminal psoralen on a third strand directed to the mutant base pair. Nucleic Acids Res 2003; 31: 4682-4688.
28. Sears LE, Zhou B, Aliotta JM, Morgan RD, Kong H. BaeI, another unusual BcgI-like restriction endonuclease. Nucleic Acids Res 1996; 24: 3590-3592.
29. Harrison B, Zimmerman SB. T4 polynucleotide kinase: Macromolecular crowding increases the efficiency of reaction at DNA termini. Anal Biochem 1986; 158: 307-315.
30. Sandor Z, Bredberg A. Repair of triple helix directed psoralen adducts in human cells. Nucleic Acids Res 1994; 22: 2051-2056.
31. Barre FX, Asseline U, Harel-Bellan A. Asymmetric recognition of psoralen interstrand crosslinks by the nucleotide excision repair and the error-prone repair pathways. J Mol Biol 1999; 286: 1379-1387.
32. Wang G, Seidman MM, Glazer PM. Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science 1996; 271: 802-805.
33. Tseng WC, Haselton FR, Giorgio TD. Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 1997; 272: 25641-25647.
34. Protic-Sabljic M, Tuteja N, Munson PJ, Hauser J, Kraemer KH, Dixon K. UV light-induced cyclobutane pyrimidine dimers are mutagenic in mammalian cells. Mol Cell Biol 1986; 6: 3349-3356.
35. Saffran WA, Cantor CR. Mutagenic SOS repair of site-specific psoralen damage in plasmid pBR322. J Mol Biol 1984; 178: 595-609.